P194 Prescribing of bisphosphonates and their impact on the risk of fractures in patients with polymyalgia rheumatica (PMR) in England: a cohort study and target-trial in the Clinical Practice Research Datalink Aurum
(2025)
Presentation / Conference Contribution
Twohig, H., Jenkinson, D., Bailey, J., Hider, S., Scott, I., & Muller, S. (2025, April). P194 Prescribing of bisphosphonates and their impact on the risk of fractures in patients with polymyalgia rheumatica (PMR) in England: a cohort study and target-trial in the Clinical Practice Research Datalink Aurum. Poster presented at British Society for Rheumatology Annual Conference 2025, Manchester Central Convention Complex, Manchester, England, UK
Background/Aims PMR is a common indication for long-term glucocorticoid (GC) treatment with real-world data on GC treatment in PMR showing that one quarter of patients continue them for >4 years. People with PMR have a 63% increased risk of fractu... Read More about P194 Prescribing of bisphosphonates and their impact on the risk of fractures in patients with polymyalgia rheumatica (PMR) in England: a cohort study and target-trial in the Clinical Practice Research Datalink Aurum.